Cytrx
Los Angeles, US · Delaware corporation
Founders & leadership
DH
d HaenExecutive
SK
Steven KreigsmanExecutive
JC
John CalozExecutive
BL
Benjamin LevinExecutive
Board
ES
Eric SelterBoard director
AC
Anita ChawlaBoard director
CC
Cheryl CohenBoard director
JR
Joseph RubinfeldBoard director
LI
Louis IgnarroBoard director
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 2 rounds · 2016–2021
▶$8.2MraisedJul 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$8.2MraisedJul 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joel CaldwellDirector
- Stephen SnowdyExecutive Officer
- Cary ClaiborneDirector
- John CalozExecutive Officer
- Jennifer SimpsonDirector
- Offering amount
- $18.2M
- Amount sold
- $8.2M
- Sales commissions
- $1.3M
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedFeb 2016 · 2 investors · BiotechnologyRule 506(c)
▶$1.3MraisedFeb 2016 · 2 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Eric SelterDirector
- Anita ChawlaDirector
- d HaenExecutive Officer
- Steven KreigsmanExecutive Officer, Director
- John CalozExecutive Officer
- Benjamin LevinExecutive Officer
- Cheryl CohenDirector
- Joseph RubinfeldDirector
- Louis IgnarroDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 05, 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Cytrx raised?
- Cytrx has disclosed $9.5M raised across 2 rounds.
- Where is Cytrx headquartered?
- Cytrx is headquartered in Los Angeles, US.